Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
5.38M
-
Shares change
-
-371K
-
Total reported value, excl. options
-
$667M
-
Value change
-
-$46M
-
Number of buys
-
8
-
Number of sells
-
-5
-
Price
-
$124.09
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2023
17 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q4 2023.
DEXCOM INC - Common Stock (DXCM) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.38M shares
of 392M outstanding shares and own 1.37% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (44.5M shares), BlackRock Inc. (32.7M shares), BAILLIE GIFFORD & CO (16.5M shares), STATE STREET CORP (16.2M shares), Capital Research Global Investors (15.3M shares), SANDS CAPITAL MANAGEMENT, LLC (15.1M shares), Capital World Investors (9.28M shares), GEODE CAPITAL MANAGEMENT, LLC (8.92M shares), FMR LLC (8.11M shares), and Nuveen Asset Management, LLC (7.49M shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.